Sort   by:  
 Page size 
UnknownAssociations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
Not available
S-EPMC3209823 | biostudies-literature
UnknownConfirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer.
Not available
S-EPMC4164116 | biostudies-literature
UnknownRisk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042.
Not available
S-EPMC2724850 | biostudies-literature
UnknownEvaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
Not available
S-EPMC3251877 | biostudies-literature
UnknownC11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Not available
S-EPMC4050669 | biostudies-literature
UnknownGenetic predisposition to mosaic Y chromosome loss in blood.
Not available
S-EPMC6887549 | biostudies-literature
UnknownGenome-wide association and longitudinal analyses reveal genetic loci linking pubertal height growth, pubertal timing and childhood adiposity.
Not available
S-EPMC3674797 | biostudies-literature
UnknownCorrection: Polygenic risk modeling for prediction of epithelial ovarian cancer risk.
Not available
S-EPMC9090804 | biostudies-literature
UnknownEmpagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC10957483 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
Sort   by:  
 Page size